75N95024R00050_Presolicitation QandA_Amendment 2.pdf
PDF 125 KB Posted
- Solicitation number
- 75N95024R00050
About this file
This document is a Presolicitation Questions and Responses related to a forthcoming Request for Proposals (RFP) No. 75N95024R00050 for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders.
The key details are as follows: The National Institutes of Neurological Disorders and Stroke (NINDS) has a need for current Good Manufacturing Practices (cGMP) manufacturing and Good Laboratory Practice (GLP) nonclinical (preclinical) support services to support translational development of therapeutic biotechnology products (Biologics) for National Institutes of Health (NIH) drug discovery and development programs. The RFP will be a Ramp-On re-opening and re-soliciting of a previous RFP, with the purpose of adding one or more contractors to the existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract pool. The ordering period for new awards will expire on September 29, 2030. The Contractor shall provide support for both Biologics cGMP manufacturing and GLP nonclinical services, including execution of the studies and completing study reports and documentation that will enable regulatory filing and evaluation of biological therapeutics in clinical trials for NIH drug development programs. Responses to specific questions indicate that offerors must propose on the entire Statement of Work, and that the requirement will not be limited to domestic sources, but foreign companies must obtain clearance from the Department of State.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 75N95024R00050_Presolicitation QandA.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PRESOLICITATION QUESTIONS AND RESPONSES
Presolicita�on No�ce No. 75N95024R00050
April 26, 2024
MANUFACTURING AND NONCLINICAL STUDIES SUPPORT FOR THE DEVELOPMENT OF THERAPEUTIC
BIOTECHNOLOGY PRODUCTS (BIOLOGICS) FOR NEUROLOGICAL RELATED DISORDERS
QUESTION 1: Can a vendor apply for Task Area 2 without applying for Task Area 1?
GOVERNMENT RESPONSE: No. Offerors must propose on the en�re Statement of Work. In cases where a vendor may not be able to fulfill all requirements using purely internal resources, vendors are encouraged to consider partnering / subcontrac�ng arrangements that would enable the vendor to complement their own internal exper�se and capabili�es.
QUESTION 2: Would our company qualify for the solicita�on?
GOVERNMENT RESPONSE: Please see the pre-solicita�on no�ce for a descrip�on of the requirement.
The solicita�on will also include all necessary informa�on and instruc�ons related to submission requirements and evalua�on criteria. All interested vendors are encouraged to apply.
QUESTION 3: Will foreign companies that would rely, in part, on manufacturing facili�es outside the U.S.
(e.g., Europe or Canada) be eligible to apply?
GOVERNMENT RESPONSE: This requirement will not be limited to domes�c sources. All eligibility requirements and mandatory qualifica�on criteria will be included in the solicita�on and all companies that meet the eligibility requirements will be eligible to apply. Clearance from the Department of State must be requested by the Government and obtained before the award of a foreign contract, foreign subcontract, or a contract with a foreign component, resul�ng from this solicita�on.
File details come from the government source that posted it. Updated .